Search Within

William Douglas Tap

Formats
  1. Journal Article (191)
  2. Meeting Abstract (159)
  3. Review (10)
  4. Book Section (4)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (2)
  8. Research Letter (1)
Groups
  1. Department of Medicine (374)
  2. Sarcoma Service (374)
  3. Solid Tumor Oncology Division (374)
  4. GSK Faculty (158)
  5. Tow Center for Developmental Oncology (TCDO) (148)
  6. Department of Pathology and Laboratory Medicine (132)

More Groups

People
  1. Sandra D'Angelo (105)
  2. Cristina Antonescu (96)
  3. Mark Dickson (91)
  4. Samuel Singer (80)
  5. Mrinal Gounder (78)
  6. Mary Keohan (76)

More People

Years
  1. 2025 (16)
  2. 2024 (50)
  3. 2023 (34)
  4. 2022 (43)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Annals of Oncology (30)
  3. Clinical Cancer Research (27)
  4. Cancer Research (14)
  5. Modern Pathology (11)
  6. Lancet Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (109)
  2. American Association for Cancer Research (48)
  3. Oxford University Press (38)
  4. Elsevier Science, Inc. (22)
  5. Elsevier Inc. (20)
  6. Nature Publishing Group (19)

More Publishers

Results (374)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Methylation analysis reveals epigenetic congruence between bone sarcomas with H3-3A mutations and malignant giant cell tumors of bone
    Journal Article

    Saoud, C.; Benhamida, J.; Borsu, L.; Villafania, L.; Linos, K.; Brannon, A. R.; Sinchun, H.; Morris, C.; Vaynrub, M.; Bartelstein, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
    Review

    Reinhorn, D.; Moskovitz, M.; Tap, W. D.; Li, B. T.
    Cancer (2025)

    Fulltext@MSK | Save
  • Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
    Journal Article

    Babatunde, O. O.; Membribes, S. C.; Anthonescu, C.; Bradic, M.; O'Malley, B.; Linkov, I.; Bartlett, E.; Momtaz, P.; Alektiar, K.; Gounder, M. M.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • Alternative driver pathways in peripheral nerve sheath tumors – Including DICER1 and/or KRAS alterations
    Journal Article

    Chang, H. Y.; Saoud, C.; Torrence, D.; Tap, W.; Chi, P.; Antonescu, C. R.
    Journal of Pathology (2025)

    Fulltext@MSK | Save
  • Peak part 1 summary: A phase 3, randomized, open-label, multicenter clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Trent, J. C.; Wagner, A. J.; Attia, S.; Agulnik, M.; Wilky, B. A.; Tap, W. D.; von Mehren, M.; Davis, E. J.; Zou, L.; Shah, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
    Journal Article

    Desai, J.; Wagner, A. J.; Carrasco Garcia, I.; Cesari, M.; Gordon, M.; Lin, C. C.; Papai, Z.; Ryan, C. W.; Tap, W. D.; Trent, J. C.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
    Meeting Abstract

    Serrano, C.; Blay, J. Y.; Rutkowski, P.; Gelderblom, H.; Stacchiotti, S.; Falcon Gonzalez, A.; Desai, J.; Le Cesne, A.; Ferraresi, V.; Palmerini, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Safety, efficacy, and patient-reported outcomes (PROs) with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received prior antiecolony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
    Meeting Abstract

    D'Amato, G.; Wagner, A. J.; Ganjoo, K. N.; Stacchiotti, S.; Gelderblom, H.; Ryan, C. W.; Palmerini, E.; Ravi, V.; Saleh, R.; Le Cesne, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Role of PIK3CA as a predictive biomarker in metastatic, imatinib-resistant GIST: A ct-DNA substudy of the VOYAGER trial
    Meeting Abstract

    Schardt, L. A.; Serrano, C.; Trent, J. C.; Krzeciesa, D.; Newberry, K.; Grassian, A.; Kang, Y. K.; Rutkowski, P.; Jones, R. L.; Heinrich, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save